![](https://cdn.cancerletter.com/media/2020/05/08124846/Gideon-Blumenthal_square.jpg)
![](https://cdn.cancerletter.com/media/2020/05/08124846/Gideon-Blumenthal_square.jpg)
Gideon Blumenthal was named vice president for Global Oncology Regulatory Affairs at Merck.
He is a former deputy director of the FDA Oncology Center of Excellence.
Gideon Blumenthal was named vice president for Global Oncology Regulatory Affairs at Merck.
He is a former deputy director of the FDA Oncology Center of Excellence.
A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.